Posttransplant donor-specific anti-HLA antibodies negatively impact pancreas transplantation outcome

American Journal of Transplantation

Volumn 11, Issue 12, 2011, Pages 2737-2746

  Cantarovich, D ^a   De Amicis, S ^a   Akl, A ^a   Devys, A ^b   Vistoli, F ^c   Karam, G ^a   Soulillou, J P ^a  

^a Institut de Transplantation et de Recherche en Transplantation (ITERT)   (France)

^b NANTES UNIVERSITY HOSPITAL   (France)

^c UNIVERSITY HOSPITAL OF PISA   (Italy)

Author keywords

Donor specific HLA antibodies; graft survival; luminex; pancreas transplantation; pancreas kidney transplantation; rejection; simultaneous

Indexed keywords

CYCLOSPORIN A; DONOR SPECIFIC ANTIBODY; HLA ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE ACETATE; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG;

ACUTE GRAFT REJECTION; ADULT; ANTIBODY SPECIFICITY; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FOLLOW UP; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY PANCREAS TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; TREATMENT OUTCOME;

ADULT; AUTOANTIBODIES; DIABETES MELLITUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; IMMUNOSUPPRESSION; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PANCREAS TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 82455171882     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2011.03729.x     Document Type: Article

References (17)

1. White SA, Shaw JA, Sutherland DER,. Pancreas transplantation. Lancet 2009; 373: 1808-1817.
2. Cantarovich D, Karam G, Hourmant M, et al,. Steroid avoidance versus steroid withdrawal after simultaneous pancreas-kidney transplantation. Am J Transplant 2005; 5: 1332-1338. (Pubitemid 40839422)
3. Crespo M, Pascual M, Tolkoff-Rubin N, et al,. Acute humoral rejection in renal allograft recipients: I. Incidence, serology and clinical characteristics. Transplantation 2001; 71: 652-658. (Pubitemid 32268068)
4. Hourmant M, Cesbron-Gautier A, Terasaki PI, et al,. Frequency and clinical implications of development of donor-specific and non-donor specific HLA antibodies after kidney transplantation. J Am Soc Nephrol 2005; 9: 2804-2812.
5. Zeevi A, Girnita A, Duquesnoy R,. HLA antibody analysis: Sensitivity, specificity, and clinical significance in solid organ transplantation. Immunol Res 2006; 36: 255-264. (Pubitemid 46398602)
6. Einecke G, Sis B, Reeve J, et al,. Antibody-mediated microcirculation injury is the major cause of kidney transplant failure. Am J Transplant 2009; 9: 2520-2531.
7. Morales-Buenrostro LE, Castro R, Terasaki PI,. A single human leukocyte antigen-antibody test after heart or lung transplantation is predictive of survival. Transplantation 2008; 85: 478-481.
8. Campbell PM, Senior PA, Salam A, et al,. High risk of sensitization after failed islet transplantation. Am J Transplant 2007; 7: 2311-2317. (Pubitemid 47347848)
9. Colombo MB, Haworth SE, Poli F, et al,. Luminex technology for anti-HLA antibody screening: Evaluation of performance and of impact on laboratory routine. Cytometry B Clin Cytom 2007; 72: 465-471. (Pubitemid 350086253)
10. Pelletier RP, Hennessy PK, Adams PW, VanBuskirk AM, Ferguson RM, Orosz CG,. Clinical significance of MHC-reactive alloantibodies that develop after kidney or kidney-pancreas transplantation. Am J Transplant 2002; 2: 134-141. (Pubitemid 36306792)
11. Torrealba JR, Samaniego M, Pacual J, et al,. C4d-positive interacinar capillaries correlates with donor-specific antibody-mediated rejection in pancreas allografts. Transplantation 2008; 86: 1849-1856.
12. de Kort H, Munivenkatappa RB, Berger SP, et al,. Pancreas allograft biopsies with positive C4d staining and anti-donor antibodies related to worse outcome for patients. Am J Transplant 2010; 10: 1669-1676.
13. Kao KJ, Scornik JC, Small JC,. Enzyme linked immunoassay for anti-HLA antibodies an alternative to panel studies by lymphocytotoxicity. Transplantation 1993; 55: 2807-2814.
14. Monien S, Salama A, Schonemann C,. ELISA methods detect HLA antibodies with variable sensitivity. Int J Immunogenet 2006; 33: 163-166. (Pubitemid 43781716)
15. Rebibou JM, Chabod J, Bittencourt MC, et al,. Flow-PRA evaluation for antibody screening in patients awaiting kidney transplantation. Transpl Immunol 2000; 8: 125-128.
16. Lachmann N, Terasaki PI, Budde K, et al,. Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts. Transplantation 2009; 27: 1505-1513.
17. Gill JS, Landsberg D, Johnston O, et al,. Screening for de novo anti-human leukocyte antigen antibodies in nonsensitized kidney transplant patients does not predict acute rejection. Transplantation 2010; 89: 178-184.